Akinobu Takaki

Medicine & Life Sciences

1. Hepatocellular Carcinoma 100%
2. Autoimmune Hepatitis 55%
3. Liver Transplantation 46%
4. Liver 32%
5. Hepatitis B virus 32%
6. Hepacivirus 29%
7. Chronic Hepatitis C 28%
8. Interferons 27%
9. Serum 25%
10. Japan 24%
11. Fatty Liver 24%
12. Non-alcoholic Fatty Liver Disease 23%
13. Oxidative Stress 22%
14. Hepatitis B 21%
15. Hepatitis 21%
16. Liver Cirrhosis 21%
17. Biliary Liver Cirrhosis 20%
18. Acute Liver Failure 19%
19. Pancreatic Neoplasms 19%
20. Genotype 19%
21. Therapeutics 17%
22. Lamivudine 16%
23. Neoplasms 16%
24. Chronic Hepatitis B 16%
25. Radiofrequency Ablation 16%
26. Recurrence 16%
27. Living Donors 15%
28. Liver Diseases 14%
29. entecavir 13%
30. Sorafenib 12%
31. Transcription Factor 3 12%
32. Polysaccharides 11%
33. glecaprevir and pibrentasvir 11%
34. Survival 11%
35. Fibrosis 11%
36. Hepatitis C 11%
37. Prothrombin 10%
38. Biomarkers 10%
39. Ribavirin 10%
40. alpha-Fetoproteins 10%
41. Hepatocytes 9%
42. Capsule Endoscopy 9%
43. Safety 9%
44. Meta-Analysis 9%
45. Cell Line 9%
46. Cisplatin 8%
47. Drug Therapy 8%
48. asunaprevir 8%
49. Massive Hepatic Necrosis 8%
50. Antioxidants 8%